Platelet-type von Willebrand disease update: The disease, the molecule and the animal model

Expert Review of Hematology

Volumn 4, Issue 5, 2011, Pages 475-477

  Othman, Maha ^a,b   Lopez, Jose A ^c,d   Ware, Jerry ^e  

^a QUEEN S UNIVERSITY   (Canada)

^b LAURENTIAN UNIVERSITY   (Canada)

^c PUGET SOUND BLOOD CENTER   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

GP1BA gene; GPIb ; platelet function defect

Indexed keywords

GLYCOPROTEIN IB ALPHA; THROMBOCYTE CONCENTRATE; VON WILLEBRAND FACTOR;

ANIMAL MODEL; DIAGNOSTIC ERROR; GENE DELETION; HUMAN; INFECTION; NONHUMAN; PHENOTYPE; PLATELET TYPE VON WILLEBRAND DISEASE; POINT MUTATION; PREGNANCY; PRIORITY JOURNAL; REVIEW; SURGICAL RISK; THROMBOCYTE; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; VON WILLEBRAND DISEASE;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MEMBRANE GLYCOPROTEINS; MUTATION; VON WILLEBRAND DISEASES;

EID: 80053188672     PISSN: 17474086     EISSN: 17474094     Source Type: Journal    
DOI: 10.1586/ehm.11.45     Document Type: Review

References (23)

1. Miller JL. Platelet-type von Willebrand disease. Thromb. Haemost. 75(6), 865-869 (1996). (Pubitemid 26355338)
2. Othman M. Platelet-type Von Willebrand disease: three decades in the life of a rare bleeding disorder. Blood Rev. 25(4), 147-153 (2011).
3. Hamilton A, Ozelo M, Leggo J et al. Frequency of platelet type versus type 2B von Willebrand disease. An international registry-based study. Thromb. Haemost. 105(3), 501-508 (2011).
4. Favaloro EJ, Patterson D, Denholm A et al. Differential identification of a rare form of platelet-type (pseudo-) von Willebrand disease (VWD) from Type 2B VWD using a simplified ristocetin-induced-platelet-agglutination mixing assay and confirmed by genetic analysis. Br. J. Haematol. 139(4), 623-626 (2007). (Pubitemid 350043816)
5. Giannini S, Cecchetti L, Mezzasoma AM, Gresele P. Diagnosis of platelet-type von Willebrand disease by flow cytometry. Haematologica 95(6), 1021-1024 (2010).
6. Sadler JE. von Willebrand factor: two sides of a coin. J. Thromb. Haemost. 3(8), 1702-1709 (2005). (Pubitemid 41716556)
7. Frangos JA, Moake JL, Nolasco L, Phillips MD, McIntire LV. Cryosupernatant regulates accumulation of unusually large VWF multimers from endothelial cells. Am. J. Physiol. 256(6 Pt 2), H1635-H1644 (1989).
8. Bodnar RJ, Xi X, Li Z, Berndt MC, Du X. Regulation of glycoprotein Iβ-IX-von Willebrand factor interaction by cAMP-dependent protein kinase-mediated phosphorylation at Ser 166 of glycoprotein Ib(b). J. Biol. Chem. 277(49), 47080-47087 (2002). (Pubitemid 36159216)
9. Shrimpton CN, Borthakur G, Larrucea S, Cruz MA, Dong JF, Lopez JA. Localization of the adhesion receptor glycoprotein Iβ-IX-V complex to lipid rafts is required for platelet adhesion and activation. J. Exp. Med. 196(8), 1057-1066 (2002). (Pubitemid 35231764)
10. Dong J, Schade AJ, Romo GM et al. Novel gain-of-function mutations of platelet glycoprotein IBa by valine mutagenesis in the Cys209-Cys248 disulfide loop. Functional analysis under statis and dynamic conditions. J. Biol. Chem. 275(36), 27663-27670 (2000).
11. Huizinga EG, Tsuji S, Romijn RA et al. Structures of glycoprotein Iba and its complex with von Willebrand factor A1 domain. Science 297(5584), 1176-1179 (2002). (Pubitemid 36196734)
12. Lou J, Zhu C. Flow induces loop-to-β-hairpin transition on the β-switch of platelet glycoprotein Ib a. Proc. Natl Acad. Sci. USA 105(37), 13847-13852 (2008).
13. Zou X, Liu Y, Chen Z, Cardenas-Jiron GI, Schulten K. Flow-induced β-hairpin folding of the glycoprotein Iba β-switch. Biophys. J. 99(4), 1182-1191 (2010).
14. Arya M, Kolomeisky AB, Romo GM, Cruz MA, Lopez JA, Anvari B. Dynamic force spectroscopy of glycoprotein Iβ-IX and von Willebrand factor. Biophys. J. 88(6), 4391-4401 (2005). (Pubitemid 40991147)
15. Doggett TA, Girdhar G, Lawshe A et al. Alterations in the intrinsic properties of the GPIba-VWF tether bond define the kinetics of the platelet-type von Willebrand disease mutation, Gly233Val. Blood 102(1), 152-160 (2003). (Pubitemid 36759649)
16. Miller JL, Kupinski JM, Castella A, Ruggeri ZM. von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease. J. Clin. Invest. 72(5), 1532-1542 (1983). (Pubitemid 14229032)
17. Suva LJ, Hartman E, Dilley JD et al. Platelet dysfunction and a high bone mass phenotype in a murine model of platelet-type von Willebrand disease. Am. J. Pathol. 172(2), 430-439 (2008). (Pubitemid 351282030)
18. Othman M, Notley C, Lavender FL et al. Identification and functional characterization of a novel 27-bp deletion in the macroglycopeptide-coding region of the GPIBA gene resulting in platelet-type von Willebrand disease. Blood 105(11), 4330-4336 (2005). (Pubitemid 40720779)
19. Ware J. Dysfunctional platelet membrane receptors: from humans to mice. Thromb. Haemost. 92(3), 478-485 (2004). (Pubitemid 39248004)
20. Miller JL, Cunningham D, Lyle VA, Finch CN. Mutation in the gene encoding the alpha chain of platelet glycoprotein Ib in platelet-type von Willebrand disease. Proc. Natl Acad. Sci. USA 88(11), 4761-4765 (1991). (Pubitemid 21914622)
21. Guerrero JA, Kyei M, Russell S et al. Visualizing the von Willebrand factor/ glycoprotein Iβ-IX axis with a platelet-type von Willebrand disease mutation. Blood 114(27), 5541-5546 (2009).
22. Kacena MA, Nelson T, Clough ME et al. Megakaryocyte-mediated inhibition of osteoclast development. Bone 39(5), 991-999 (2006). (Pubitemid 44528382)
23. Beeton CA, Bord S, Ireland D, Compston JE. Osteoclast formation and bone resorption are inhibited by megakaryocytes. Bone 39(5), 985-990 (2006). (Pubitemid 44528392)